This web seminar shows the characteristics and advantages of TTS in relation to the feasibility of its usage to better/alternatively administer pharmaceutical actives and the novel possibilities to assess these advantages. The web seminar will explore the history of the market success of TTS and the reasons therefore. The web seminar will also give an outlook on what is coming next in transdermal drug delivery e.g. microneedle systems.
Presented by Dr. Marco Emgenbroich, Corporate Vice President Head of Pharmaceutical Development